Innovaccer Inc., a leading healthcare AI company, today announced the launch of a comprehensive, AI-powered Readmissions Management Solution designed to help health systems and providers reduce avoidable readmissions,

Remedy Logic, a pioneer in radiology artificial intelligence, today announced it has signed a partnership agreement with RADIN Health® a leading cloud-based, all-in-one, RIS, PACS, Dictation AI®, and Select® workflow management solution

King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first implantation of two artificial pumps for biventricular support (BiVAD-HMIII) using robotic technology

Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced new data for its AI-enabled Heartflow Plaque Analysis, including final primary endpoint data from the DECIDE Registry.

Piccolo Medical, Inc. (Piccolo), a leading innovator in vascular access technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its next-generation SmartPICC®

Varian, a Siemens Healthineers company, today announced the European launch of IntelliBlate, its next-generation microwave ablation solution for the treatment of soft tissue tumors

ShiftMed, a leading provider of healthcare workforce technology, today announced the launch of its Workforce AI Suite, a set of intelligent tools designed to automate shift fulfillment and optimize workforce management.

GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced the company has completed the close of its oversubscribed $53 million Series D equity financing.

Intuitive, a global leader in minimally invasive care and robotic-assisted surgery, has received clearance from the U.S. Food and Drug Administration (FDA) for its Vessel Sealer Curved instrument, designed for use with the company's multiport da Vinci surgical systems.

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the company’s